ODPRN Citizens’ Panel

The ODPRN Citizens’ Panel is a group of 21 volunteer citizens from across Ontario who have collectively come together to ensure that the ODPRN appropriately identifies issues of importance to the public, and incorporates these priorities into all aspects of our research.

odprn-citizens-panel-2016Members

Adriana Perez Jerome Johnson
Angela Sinclair Josephine Quercia
Anne MacDonald Kris Lee
Carlos Robayo Kristen Morin
Dave D’Oyen Lorraine Bayliss
Debbie Rotenberg Matt Joosse
Donna May Priya Chendke
Elizabeth Bojarski Suzanne Pierson
Helen Patten Terry Ebejer
Jane Sanders Valerie South
Jennifer Jilks Vincent Tourangeau

Involvement

In addition to meeting bi-monthly to provide their input on current research projects and deliverables, members also participated in a two-day workshop to define their role, structure and governance:

  • Identifying priority research areas: Currently, members are collectively developing a research project of joint interest to policymakers, researchers and the general public based on aligned research priorities.
  • Integrating members with researchers & policymakers: This includes several leadership roles within the Citizens’ Panel, such as membership within our Core Academic Unit and opportunities for engagement with drug policy makers.
  • Participating on research teams: Currently, members are individually working on specific projects of interest to them. This includes reviewing dissemination material to ensure that our research is understandable to the general public.
  • Enhancing patient engagement: Members are formally acknowledged on published material and have been instrumental in developing patient engagement tools including an online drug policy training module.

Citizens Panel PosterInterested in becoming a Member?

If you are interested in becoming a member of the ODPRN Citizens’ Panel please email Dana Shearer, Knowledge Broker at shearerd@smh.ca for more information.

Please note that this report is NOT COMPLETE and is still in progress. Click below if you would like to continue.